Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Stroke code simulation benefits advanced practice providers similar to neurology residents.

Khan M, Baird GL, Price T, Tubergen T, Kaskar O, De Jesus M, Zachariah J, Oostema A, Scurek R, Coleman RR, Sherman W, Hingtgen C, Abdelhak T, Smith B, Silver B.

Neurol Clin Pract. 2018 Apr;8(2):116-119. doi: 10.1212/CPJ.0000000000000435.

2.

Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.

Wolters PL, Martin S, Merker VL, Tonsgard JH, Solomon SE, Baldwin A, Bergner AL, Walsh K, Thompson HL, Gardner KL, Hingtgen CM, Schorry E, Dudley WN, Franklin B; REiNS International Collaboration.

Neurology. 2016 Aug 16;87(7 Suppl 1):S4-S12. doi: 10.1212/WNL.0000000000002927.

3.

N-type calcium current, Cav2.2, is enhanced in small-diameter sensory neurons isolated from Nf1+/- mice.

Duan JH, Hodgdon KE, Hingtgen CM, Nicol GD.

Neuroscience. 2014 Jun 13;270:192-202. doi: 10.1016/j.neuroscience.2014.04.021. Epub 2014 Apr 19.

4.

Neurofibromin-deficient myeloid cells are critical mediators of aneurysm formation in vivo.

Li F, Downing BD, Smiley LC, Mund JA, Distasi MR, Bessler WK, Sarchet KN, Hinds DM, Kamendulis LM, Hingtgen CM, Case J, Clapp DW, Conway SJ, Stansfield BK, Ingram DA Jr.

Circulation. 2014 Mar 18;129(11):1213-24. doi: 10.1161/CIRCULATIONAHA.113.006320. Epub 2013 Dec 26.

5.

Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.

Wolters PL, Martin S, Merker VL, Gardner KL, Hingtgen CM, Tonsgard JH, Schorry EK, Baldwin A; REiNS International Collaboration.

Neurology. 2013 Nov 19;81(21 Suppl 1):S6-14. doi: 10.1212/01.wnl.0000435747.02780.bf. Review.

6.

Schwannomatosis: the overlooked neurofibromatosis?

Koontz NA, Wiens AL, Agarwal A, Hingtgen CM, Emerson RE, Mosier KM.

AJR Am J Roentgenol. 2013 Jun;200(6):W646-53. doi: 10.2214/AJR.12.8577. Review.

PMID:
23701098
7.

Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.

Nutakki K, Hingtgen CM, Monahan P, Varni JW, Swigonski NL.

Health Qual Life Outcomes. 2013 Feb 21;11:21. doi: 10.1186/1477-7525-11-21.

8.

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

Robertson KA, Nalepa G, Yang FC, Bowers DC, Ho CY, Hutchins GD, Croop JM, Vik TA, Denne SC, Parada LF, Hingtgen CM, Walsh LE, Yu M, Pradhan KR, Edwards-Brown MK, Cohen MD, Fletcher JW, Travers JB, Staser KW, Lee MW, Sherman MR, Davis CJ, Miller LC, Ingram DA, Clapp DW.

Lancet Oncol. 2012 Dec;13(12):1218-24. doi: 10.1016/S1470-2045(12)70414-X. Epub 2012 Oct 23.

9.

Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides.

Wilson SM, Schmutzler BS, Brittain JM, Dustrude ET, Ripsch MS, Pellman JJ, Yeum TS, Hurley JH, Hingtgen CM, White FA, Khanna R.

J Biol Chem. 2012 Oct 12;287(42):35065-77. doi: 10.1074/jbc.M112.378695. Epub 2012 Aug 13.

10.

Dorsal root ganglia isolated from Nf1+/- mice exhibit increased levels of mRNA expression of voltage-dependent sodium channels.

Hodgdon KE, Hingtgen CM, Nicol GD.

Neuroscience. 2012 Mar 29;206:237-44. doi: 10.1016/j.neuroscience.2011.12.045. Epub 2012 Jan 8.

PMID:
22260870
11.

Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.

Brittain JM, Duarte DB, Wilson SM, Zhu W, Ballard C, Johnson PL, Liu N, Xiong W, Ripsch MS, Wang Y, Fehrenbacher JC, Fitz SD, Khanna M, Park CK, Schmutzler BS, Cheon BM, Due MR, Brustovetsky T, Ashpole NM, Hudmon A, Meroueh SO, Hingtgen CM, Brustovetsky N, Ji RR, Hurley JH, Jin X, Shekhar A, Xu XM, Oxford GS, Vasko MR, White FA, Khanna R.

Nat Med. 2011 Jun 5;17(7):822-9. doi: 10.1038/nm.2345.

12.

Reduced expression of SynGAP, a neuronal GTPase-activating protein, enhances capsaicin-induced peripheral sensitization.

Duarte DB, Duan JH, Nicol GD, Vasko MR, Hingtgen CM.

J Neurophysiol. 2011 Jul;106(1):309-18. doi: 10.1152/jn.00963.2010. Epub 2011 Apr 27.

13.

Ras signaling pathways mediate NGF-induced enhancement of excitability of small-diameter capsaicin-sensitive sensory neurons from wildtype but not Nf1+/- mice.

Duan JH, Wang Y, Duarte D, Vasko MR, Nicol GD, Hingtgen CM.

Neurosci Lett. 2011 Jun 1;496(2):70-4. doi: 10.1016/j.neulet.2011.03.083. Epub 2011 Apr 8.

14.

Ret-dependent and Ret-independent mechanisms of Gfl-induced sensitization.

Schmutzler BS, Roy S, Pittman SK, Meadows RM, Hingtgen CM.

Mol Pain. 2011 Mar 30;7:22. doi: 10.1186/1744-8069-7-22.

15.

Signaling pathways that mediate nerve growth factor-induced increase in expression and release of calcitonin gene-related peptide from sensory neurons.

Park KA, Fehrenbacher JC, Thompson EL, Duarte DB, Hingtgen CM, Vasko MR.

Neuroscience. 2010 Dec 15;171(3):910-23. doi: 10.1016/j.neuroscience.2010.09.027. Epub 2010 Sep 24.

16.

ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.

Wang Y, Brittain JM, Wilson SM, Hingtgen CM, Khanna R.

Transl Neurosci. 2010 Jun;1(2):106-114.

17.

Augmented sodium currents contribute to the enhanced excitability of small diameter capsaicin-sensitive sensory neurons isolated from Nf1+/⁻ mice.

Wang Y, Duan JH, Hingtgen CM, Nicol GD.

J Neurophysiol. 2010 Apr;103(4):2085-94. doi: 10.1152/jn.01010.2009. Epub 2010 Feb 17.

18.

Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans.

Lasater EA, Li F, Bessler WK, Estes ML, Vemula S, Hingtgen CM, Dinauer MC, Kapur R, Conway SJ, Ingram DA Jr.

J Clin Invest. 2010 Mar;120(3):859-70. doi: 10.1172/JCI41443. Epub 2010 Feb 15.

19.

Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons.

Chi XX, Schmutzler BS, Brittain JM, Wang Y, Hingtgen CM, Nicol GD, Khanna R.

J Cell Sci. 2009 Dec 1;122(Pt 23):4351-62. doi: 10.1242/jcs.053280. Epub 2009 Nov 10.

20.

Glial cell line-derived neurotrophic factor family ligands enhance capsaicin-stimulated release of calcitonin gene-related peptide from sensory neurons.

Schmutzler BS, Roy S, Hingtgen CM.

Neuroscience. 2009 Jun 16;161(1):148-56. doi: 10.1016/j.neuroscience.2009.03.006. Epub 2009 Mar 11.

21.
22.

Involvement of platelet-activating factor in ultraviolet B-induced hyperalgesia.

Zhang Q, Sitzman LA, Al-Hassani M, Cai S, Pollok KE, Travers JB, Hingtgen CM.

J Invest Dermatol. 2009 Jan;129(1):167-74. doi: 10.1038/jid.2008.181. Epub 2008 Jun 26.

23.

Injection of autologous muscle stem cells (myoblasts) for the treatment of vocal fold paralysis: a pilot study.

Halum SL, Naidu M, Delo DM, Atala A, Hingtgen CM.

Laryngoscope. 2007 May;117(5):917-22.

PMID:
17473696
24.

Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.

Nebesio TD, Ming W, Chen S, Clegg T, Yuan J, Yang Y, Estwick SA, Li Y, Li X, Hingtgen CM, Yang FC.

Glia. 2007 Apr 1;55(5):527-36.

PMID:
17236191
26.

Stimulus-evoked release of neuropeptides is enhanced in sensory neurons from mice with a heterozygous mutation of the Nf1 gene.

Hingtgen CM, Roy SL, Clapp DW.

Neuroscience. 2006;137(2):637-45. Epub 2005 Nov 17.

PMID:
16298082
27.

Sensory neurons from Nf1 haploinsufficient mice exhibit increased excitability.

Wang Y, Nicol GD, Clapp DW, Hingtgen CM.

J Neurophysiol. 2005 Dec;94(6):3670-6. Epub 2005 Aug 10.

28.

Isolation and culture of sensory neurons from the dorsal-root ganglia of embryonic or adult rats.

Burkey TH, Hingtgen CM, Vasko MR.

Methods Mol Med. 2004;99:189-202.

PMID:
15131338
29.

Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.

Yang FC, Ingram DA, Chen S, Hingtgen CM, Ratner N, Monk KR, Clegg T, White H, Mead L, Wenning MJ, Williams DA, Kapur R, Atkinson SJ, Clapp DW.

J Clin Invest. 2003 Dec;112(12):1851-61.

30.

Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands.

Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, Tanzi RE, Moir RD, Nath A, He JJ.

Nat Med. 2000 Dec;6(12):1380-7.

PMID:
11100124
31.

The tragedy of Sergei Prokofiev.

Hingtgen CM.

Semin Neurol. 1999;19 Suppl 1:59-61.

PMID:
10718530
32.
33.

The treatment of Parkinson's disease: current concepts and rationale.

Hingtgen CM, Siemers E.

Compr Ther. 1998 Nov-Dec;24(11-12):560-6. Review.

PMID:
9847972
35.
36.
37.

Supplemental Content

Loading ...
Support Center